Grantham, Mayo, Van Otterloo & Co (GMO)’s M.D.C. Holdings, Inc. MDC Stock Holding History
Bought
Maintained
Sold
Other funds holding MDC
C
HCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s MDC Position: Q4 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of M.D.C. Holdings, Inc. (MDC) in Q4 2022, closing a stake of 7,608 shares — an estimated $209K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MDC in Q1 2017 and held it in 18 quarters. The position peaked at $17.3M in Q1 2021. 307 funds tracked by Wall St. Rank hold MDC as of Q4 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining M.D.C. Holdings, Inc. position as of Q4 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,608 M.D.C. Holdings, Inc. shares in Q4 2022, an estimated $209K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in M.D.C. Holdings, Inc. in Q1 2017 and held it in 18 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s M.D.C. Holdings, Inc. position peaked at $17.3M in Q1 2021.
- 307 funds tracked by Wall St. Rank held M.D.C. Holdings, Inc. as of Q4 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2022, filed 13 Feb 2023.